Expression of hypoxia-inducible factor-1-α, hypoxia-inducible fator-2α and vascular endothelial growth factor in sporadic clear cell renal cell carcinoma and their significance in the pathogenesis thereof

National Medical Journal of China

Volumn 86, Issue 22, 2006, Pages 1526-1529

  Zhang, Ning ^a   Gong, Kan ^a   Yang, Xin Yu ^a   Xin, Dian Qi ^a   Na, Yan Qun ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Hypoxia inducible factor; Kidney neoplasmas; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CAPILLARY DENSITY; CARCINOGENESIS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY SURGERY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33748302779     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr Opin Genet Dev, 2001, 11: 293-299.
2. Chinese source. 2005, 43:390-393.
3. Haddad JJ. Oxygen sensing and oxidant/redox-related pathways. Biochem Biophys Res Commun, 2004, 316: 969-977.
4. Weidener N. Current pathologic methods for measuring intraturmoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat, 1995, 36: 169-173.
5. Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem, 1993, 268: 21513-21518.
6. Chinese source. 2004,84:1620-1624.
7. Liu MY, Poellinger L, Walker CL. Up-regulation of hypoxia-inducible factor 2 alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Cancer Res, 2003, 63:2675-2680.
8. Bardos JI, Ashcroft M. Hypoxia-inducible factor-1 and oncogenic signalling. Bioessays, 2004, 26: 262-269.
9. Erez N, Milyavsky M, Eilam R, et al. Expression of prolylhydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth. Cancer Res, 2003, 63: 8777-8783.
10. Josko J, Mazurek M. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit, 2004, 10: RA89-RA98.
11. Na X, Wu G, Ryan CK, et al. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas. J Urol, 2003, 170: 588-592.
12. Turner KJ, Moore JW, Jones A, et al. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res, 2002, 62: 2957-2961.
13. Jiang Y, Zhang W, Kondo K, et al. Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways. Mol Cancer Res, 2003, 1: 453-462.
14. Seagroves T, Johnson RS. Two HIFs may be better than one. Cancer Cell, 2002, 1: 211-213.
15. Elvert G, Lanz S, Kappel A, et al. mRNA cloning and expression studies of the quail homologue of HIF-2 alpha. Mech Dev, 1999, 87: 193-197.